TRENDING

TECHNOLOGY NEWS FROM AROUND THE WORLD

→
Nature MedicineNEWS
Nature MedicineNEWS

Next-generation KRAS G12C inhibitor improves survival in lung cancer

Nature Medicine, Published online: 10 November 2026; doi:10.1038/d41591-026-00057-9 Phase 3 trial data show that the next-generation KRAS G12C inhibitor divarasib leads to longer progression-free…

Published: Nov 10, 2026·Nature Medicine
Read at original source ↗
0 reads

Comments

No comments yet. Be the first to contribute.

✎ Write a comment